Laboratory Screening Procedures and Their Clinical Implications [ Abridged ]

Efron M L Young D Moser H W MacCready R A . (1964) New Engl. J. Med. 270, 1378.

Farquhar J W Kansas E T Tait H P . (1962) Lancet ii, 498.

Gibbs N K Woolf L I . (1959) Brit. med. J. ii, 532.

Guthrie R Susi A . (1963) Pediatrics 32, 338.

Hill J B Summer G K Pender M W Roszel N O . (1965) Clin. Chem. 11, 541.

Scriver C R Davies E Cullen A M . (1964) Lancet ii, 230.

Searle B Mijuskovic M B Widelock D Davidow B . (1967) Clin. Chem. 13, 621.

Stephenson J B P McBean M S . (1967) Brit. med. J. iii, 582.

Woolf L I . (1961) Cerebr. Palsy Bull. 3, 249.

Woolf L I . (1962) Lancet ii, 663.

Woolf L I . (1963a) Advanc. clin. Chem. 6, 97.

Woolf L I . (1963b) In: Phenylketonuria. Ed. Lyman F L . Springfield, Ill.; p 251.

Woolf L I . (1967a) Brit. med. J. iii, 862.

Woolf L I . (1967b) In: Phenylketonuria and Allied Metabolic Diseases. Ed. Anderson J A Swaiman K F . US Department of Health, Education, and Welfare, Washington; p 50.

Woolf L I Ounsted C Lee D Humphrey M Cheshire N M Steed G R . (1961) Lancet ii, 464.